Microsoft word - kenetcv.rtf

Place of work:
Phone: 5302409/2120

Faculty:
Department: Hematology

Telephone:

Date and place of birth:

Zahal military service:

Marital status:
EDUCATION
Hadassah Medical School, Hebrew University, Jerusalem 1983 Bachelor of Science in Basic Life Sciences 1986 Elective internship in Montreal Children's Hospital during exchange program for outstanding students. Supervisors: Amir N., Pediatric Neurologist, Bikur Holim Hospital, Jerusalem. Peer J., Pediatric Ophthalmology, Hadassah Ein-Kerem, Jerusalem. ACADEMIC EXPERIENCE
Training with Prof. G. Zaijcek, Head of Medical Computer Unit and Oncology researcher, Hadassah Ein-Kerem Hospital, Jerusalem. Clinical research with autologous cord blood transfusion. Pediatric department and Hematology Department The E. Wolfson Medical Center, Israel. Instructor in Pediatrics Tel Aviv University, Sackler School of Medicine, Israel. Instructor in Hematology, Tel Aviv University, Sackler School of Medicine, Israel. Research projects on platelet function, childhood stroke, and pediatric solid tumors. Pediatric Hematology Oncology Department and Inst. Of Thrombosis and Haemostasis, Sheba Medical Center. Since 1999 Research projects on Recombinant Factor VIIa and mutation analysis of Hemophilia in Israel 2001 Lecturer in Hematology, Tel Aviv University, CLINICAL EXPERIENCE:
Internship - The E. Wolfson Medical Center Division of Pediatrics, E. Wolfson Medical Center Internship - Institute of Hematology, The Chaim Sheba Medical Center, Tel-Hashomer Specialist in Pediatric Hemato-Oncology. Responsible for Pediatric Thrombosis and Hemostasis Service, The Chaim Sheba Medical Center, Tel-Hashomer, and the National Hemophilia Center, Tel-Hashomer. Since 1996 Director- Israeli Pediatric Thrombophilia registry June 2001 Director, Pediatric Coagulation Service, The National
E. ACADEMIC AND PROFFESIONAL AWARDS
1993 The Stenly Levin foundation research award of the Society of Clinical Pediatrics
F. MEMBERSHIP IN PROFFESIONAL SOCIETIES
1987 Israel Medical Association
1988 Israel Society of Clinical Pediatrics
1994 Israel Society of Hematology and Blood Transfusion
1995 Israel Society of Pediatric Hematology and Oncology
1998 Israel Society of Thrombosis and Haemostasis
1999 World Federation of Hemophilia
1999 Member of the editorial board of the Hemophilia Forum
2000 Member of the International Advisory Board of Novonordisk
2001 American Society of Hematology
2001 International Society of Thrombosis and Hemostasis (ISTH)
2002 Cochair- Scientific Subcommittee of ISTH for Pediatric and Neonatal Thrombosis
2003 Reviewer- Thrombosis and Hemostasis
G. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS
1989-1992, 1994, 1997, 1999, 2003
Meetings of the Israeli Society Clinical Pediatrics Meetings of the Israeli Society of Hematology 1993, 1995-2003 Meetings of the the Israeli Society of Pediatric Hematology- Meetings of the Israeli Society of Thrombosis and Hemostasis XVth Congress of the International Society of Thrombosis and Haemostasis (ISTH), Jerusalem, Israel XVIth Congress of the ISTH, Florence, Italy The XXIII Congress of the World Federation of Hemophilia (WFH), Hague, The Netherlands XVIIth Congress of ISTH, Washington DC, USA
2001 GTH-The German Society of Thrombosis
research, Dusseldorf, Germany
The Novonordisk symposium on the treatment of
bleeding and thrombotic disorders
2001 The annual Pediatric Hematology Congress-
Ankara, Turkey
2001 The 43 ASH, Orlando, USA
2002 WFH congress, Seville, Spain
2002 SSC of ISTH, Boston, USA
2003 ASBMT meeting, Keystone, USA

2003 XIX congress ISTH, Birmingham, UK
2004 SSC of ISTH, Venice, Italy
2004 WFH congress, Bangkok, Thailand

STUDENTS SUPERVISED BY CANDIDATE

1992-2004
Weekly bedside and frontal instruction in hematology to Israeli and American medical students in the Pediatric Hematology Department and (since 1996) the Institute of Thrombosis and Haemostasis and the National Hemophilia Center at the Chaim Sheba Medical Center, Tel Hashomer הטלוקפב ראותה תושירדמ קלחכ ליונייטש הירא רגובה לש רמג תדובע עוציבב Cone and plate(let) analyzer as a predictor for blood loss after cardiopulmonary bypass
LIST OF PUBLICATIONS

B1 Original articles

1.
Ballin A, Kenet G, Tamany H, Rechavi G, Chividalli Y, Burstein Z, Tauber M. Nussinovitch D, Meytes D. Infantile idiopathic thrombocytopenic purpura. Lishner M, Kenet G, Lalkin A, Yarkoni S, Ben-Bassat I, Fejgin M, Rechavi G, Amiel A. Fluorescent in situ hybridization for the detection of t(8:14) in Burkitt's lymphoma. Acta-Haematol 90(4):186-9, 1993 Mandel M, Toren A, Kende G, Neumann Y, Kenet G, Rechavi G. Familial clustering of malignant germ cell tumors and Langerhans' histiocytosis. Cancer 73(7):1980-3, 1994 Ballin A, Kenet G, Gutman R, Samra Z, Zakut H, Meytes D. Kende G, Toren A, Ben-Bassat I, Mandel M, Neumann Y, Kenet G, Rechavi G. Familial congenital amegakaryocytic thrombocytopenia occurring in females only. Int J Ped Hematol Oncol 2:35-37, 1995. Cervical lymphadenopathy as a sign of atopy in childhood. J Allergy Clin Immunol 96(2):164-5, 1995 Gilad E, Paret G, Katz M, Vardi A, Kenet G, Barzilay Z. Plain radiography for diagnosis of gastrointestinal perforation in immune compromised children -- is it enough? Ballin A, Arbel E, Kenet G, Berar M, Kohelet D, Tanay A, Zakut H, Meytes D. Autologous umbilical cord blood transfusion. Arch Dis Child Fetal Neonatal Ed 73(3):181-183, 1995 Toren A, Sharon N, Mandel M. Neumann Y, Kenet G, Kaplinsky C, Dor J, Rechavi G. Two embryonal cancers after in vitro fertilization. Inbal A, Kenet G, Zivelin A, Yermiyahu T, Bronstein T, sheinfeld T, Tamari H,Gitel S, Eshel G, Duchemin J, Aiach M, Seligsohn U. Purpura fulminans induced by disseminated intravascular coagulation following infection in two unrelated children with double heterozygosity for factor V leiden and Protein S defficiency. 11. Kenet G, Lubetsky A, shenkman B, Tamari I, Darkik R, Rechavi G, Barzilai A, Martinovitz U, Savion N, Varon D. Core and platelet analyser (CPA): a new test for the prediction of bleeding among thrombocytopenic patients. British Journal of Haematology 101:255-259,1998 Kaplinsky C, Kenet G, Seligsohn U, Rechavi G. Association between hyperflexibility of the thumb and an unexplained bleeding tendency: is it a rule of thumb? British Journal of Hematology 101:260-263,1998 Cohen H., Harel L., Paret G., Lahat E., Kenet G, Barzilai A: Aurioscope earpieces- a potential vector of infection? International journal of Pediatric Otorhinolaryngology 45:47-50, 1998 Shenkman B., Linder N., Savion N., Tamarin I., Dardik R., Kenet G., German B., Varon D: Increased Neonatal Platelet Deposition on Subendothelium under Flow Conditions: The role of plasma von Willebrand Factor. Hayek S*, Kenet G*, Lubetsky A, Rosenberg N, Gitel S, Weintroub S. Does thrombophilia play an etiological role in Legg-Calve-Perthes disease? Journal f Bone and Joint Surgery. 81-B(4):686-690, 1999 *equally contributed as first authors in different disciplines 16. Lubetsky A., Schulman S., Varon D., Martinowitz U., Kenet G., Sanford G., Inbal A: Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate P™) in patients with von Willebrand disease. 17. Kenet G, Freedman J, Shenkman B, Brok-Simoni F, Holzman F, Brand N, Michelson A, Loscalzo J, Inbal A. Plasma Glutathione Peroxidase deficiency and platelet insensitivity to Nitric Oxide in children with familial stroke. Arterioscler. Thromb Vasc Biol 19:2017-2023,1999



18. Kenet G., Lubetsky A., Gitel S., Luboshitz J., Varon D and Martinowitz U:
Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison
of two treatment protocols with recombinant activated factor VIIa.
Blood Coagulation and Fibrinolysis 11;Suppl S35-38,2000
19. Kenet G, Sadetzki S., Murad H., Martinowitz U., Rosenberg N., Gitel S., Rechavi G.,
Inbal A: Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 31; (6) 1283-1288, 2000 20. Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, Lynn M: Recombinant activated factor VII (rFVIIa) for adjunctive hemorrhage control in trauma. J of Trauma 51;(3) 431-438, 2001 21. A Lubetsky, U. Martinowitz, J. Luboshitz , G. Kenet , N. Keller , I. Tamarin , R. Dardik A. Inbal. Efficacy and Safety of a Factor VIII - von Willebrand Factor Concentrate 8Y: Stability, Bacteriological Safety, Pharmacokinetic Analysis and Clinical Experience. Hemophilia,8; 622-628;2002 22. Martinowitz U, Kenet G, lubetsky A, Luboshitz J, Segal E. Possible role of recombinant activated factor VII in the control of hemorrhage associated with massive trauma. Can J Anest 49 (10);S15-S20:2002 23. Kenet G: The use of rFVIIa (NovoSeven®) for hemorrhage control in trauma 24. Kenet G, Lubetsky A, Luboshitz J, Martinowitz U: A New Approach to Treatment of Bleeding Episodes in Young Hemophilia Patients: a Single Bolus Mega-dose of Recombinant Activated Factor VII (NovoSeven®) JTH 1 (3); 450-455, 2003 25. Kenet G, Hayek S, Mor M, Lubetsky A, Miller L, Rosenberg N, Mosheiff R, Itzhaki M, Elstein D, Weintroub S, Zimran A: The 1226G (N370S) Gaucher mutation among patients with Legg-Calve- Perthes disease. Blood Cells Molec Dis 31 (1);72-74, 2003 26. Kenet G, Maayan A, Rosenberg N, Sela BA, Mazkereth R, Yifra A, Kuint J. Thrombophilia does not increase the risk for neonatal complications in preterm infants. Thromb Haemost 90: 823-8; 2003 27. Inbal A, Kenet G . Pregnancy and surgical procedures in patients with factor XIII deficiency. Biomedical Progress 16:69-71; 2003 28. Kenet G , Waldman D, Lubetsky A, Kornbrut N, Chalil A, Koren A, Wolach B, Fattal A, Kapelushnik Y, Tamary H, Yacobovitch J, Raveh E,Revel-Vilk S , Toren A, Brenner B. Pediatric Cerebral Sinus Vein Thrombosis- a Multi-center Case-controlled Study. Thromb Haemost 92: 707-713; 2004, 29. Kenet G, Lubetsky A, Luboshitz J, Ravid B, Tamarin I, Martinowitz U High dose recombinant activated factor VII for treatment of patients with hemophilia and inhibitors journal of Thrombosis and Thrombolysis 2004, in press 30. Fattal-Valevsky A, Kenet G, Kuperminc M, Mesterman R, Leitner Y, rimon E, Harel S, hassner A. The role of thrombophilic risk factors in children with cerebral palsy. J (accepted) Thromb Res 31. Luboshitz J, Lubetsky A, shenkman B, lelazari S, Kenet G, cattaneo M, Savion N, Varon D The cone and plate(let0 analyser as a point of care test for diagnosis and monitoring of replacement therapy in von-Willebrand disease (submitted-JTH)
B2 CASE REPORTS

1.
Toren A, Kende G, Mandel M, Biniaminov M, Brok-Simoni F, Rosenthal E, Engelberg I, Neumann Y, Kenet G, Ben-Bassat I, et-al. In vivo clonal evolution of pre-B to B-cell acute lymphoblastic leukemia in childhood. Kende G, Toren A, Mandel M, Neumann Y, Kenet G, Ben-Bassat I, Rechavi G. Familial leukemia: description of four kindreds and a review of the genetic aspects of the disease. Acta Hematologica 92(4):208-11,1994 Berkowicz M, Toren A, Rosner E, Mandel M, Vonsover A, Biniaminov M, Amariglio N, Mark Z, Kenet G, Neumann Y, et-al. Lymphomatous T-cell leukemia in two Arab children. Is there a role for an environmental effect? G, Mandel M, Mor Y, Toren A, Jonas P, Neumann Y, Kende G, Rechavi G. Genetic predisposition and cyclophosphamide treatment in a girl with bladder carcinoma. Med Ped Oncol 24(4):269-270,1995 5. Neumann Y, Toren A, Rechavi G, Seigried B,Shoham NG, Mandel M, Kenet G, Sharon N, Sadeh M, Navon R. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease. Med Pediatr Oncol 26(4):280-3,1996 6. Toren A, Neumann Y, Rosner E, Schiby G, Paret G, Biniaminov M, Amariglio N, Mark Z, Mandel M, Kenet G, Bercowicz M, Rubnov V, Rosenthal E, Brok-simoni F, Rechavi G. Pediatric small cell variant of Ki-1 (CD30) + T-cell lymphoma with germ-line configuration of the T-cell receptor gene. 7. Toren A, Mandel M, Passwell J, Biniaminov M, Neumann Y, Rosenthal E, Kende G, Kenet G, Brok-Simoni F, Rechavi G. Lack of N-myc-amplification and normal karyotype in stage IV-N neuroblastoma. Acta Oncol 35(4):496-8, 1996 8. Kaplinsky C, Toren A, Neumann Y, Mandel M, Kenet G, Sharon N, Rechavi G, Biniaminov M, Rubanov V, Rosenthal E, Rosner E, Mark Z, Amariglio N, Brok-Simoni F. Central Nervous system involvement at diagnosis in a case of pediatric CD30+ anaplastic large cell lymphoma. Med Pediatr Oncol 28(2):132-5,1997 9. Sharon N, Kenet G, Toren A, Mandel M, Neumann Y, Kaplinsky C, schiby G, Rechavi G. Helicobacter pylori-associated gastric lymphoma in a girl. Pediatr Hematol Oncol 14(2):177-80,1997 10. Kenet G, Sharon N, rosner E, Toren A, Neumann Y, Mandel M, Kaplinsky C, Gipsh N, Berman S, Rechavi G. Chromosomal translocation (1:13) in a case of alveolar rhabdomyosarcoma. J Ped hematol Oncol 20(1):86-7,1998. Kenet G., Walden R, Eldad A, Martinowitz U: Treatment of traumatic bleeding with recombinant factor VIIa. The Lancet 354; (9193):1879,1999 Sharon N, Neumann Y, Kenet G, Schachter J, Rechavi G, Toren A: Successful pregnancy after high-dose Cyclophosphamide and Ifosfamide treatment in two postpubertal women. Ped Hematol Oncol 18:247-252, 2001 Leibovitch L, Kenet G, mazor K, Matok I, Vardi A, Barzilay Z, Paret G. Recombinant activated factor VII for life threatening pulmonary hemorrhage following pediatric cardiac surgery Ped Crit Care Med 4 (4):444-6; 2003

B3 REVIEW ARTICLES

1. Balin A., Kenet G: Autologous cord blood transfusion. Harefuah 124(9):554-556,1993
1993 554-556 ,124 האופרה .ררושה םד לש ימצע יוריע :ג תנק ,.ע ןילאב
2.
Goldstein G, Kenet G: The impact of chronic disease on the family. Haemophilia 8(3), 461- 465; 2002 Abshire T, Kenet G: Recombinant activated factor VII: Review of efficacy, dosing regimens and safety in patients with hemophilia and FVIII or FIX inhibitors, or acquired hemophilia JTH 2 (6), 899-909; 2004 Brenner B, Grabowski EF, Hellgren M, Kenet G, Massicote P, Manco-Johnson M, Mathew P, Muntean W, Schleggel N, Nowak-Gottl G: Thrombophilia and pregnancy complications Thromb Haemost 92 (4) 678-681; 2004 Ravel-Vilk S, Kenet G : Thrombophilia in children with venous thromboembolic disease Thromb Res 2004 (accepted)

B4 CHAPTERS IN BOOKS:
In: Pediatrics, Ashkenazi S, Shohat M. (Hebrew). Dionon University of Tel-Aviv press. Vol. 4 p. 717-765, 1994. Pediatrics, Ashkenazi S, Shohat M. (Hebrew). Dionon University of Tel-Aviv press. Vol. 4 p. 717-765, 1994. 3. Kaplinsky C., Kenet G., Rechavi G: Coagulation, bone marrow and blood cells, immune system. Principals and practic of Pediatric Anesthesia. Editors: Bernard Dalens and Bruno Bissonnette, McGraw Hill, New York USA, 2000. 4. Kenet G :Bleeding disorders in neonates. Women’s issues in Hemostasis. Editors: Brenner B, Marder VJ, Conrad J. Martin Dunitz Publishers, London, UK, 2002 5. Kenet G, Martinowitz U: Standard high and mega bolus doses of rFVIIa: Comparison of three treatment regimens. Inhibitors in patients with Haemophilia Editors:EC Rodriguez-Merchan, CA Lee. Blackwell-Science, USA, 2002
D2 PAPERS PRESENTED AT SCIENTIFIC MEETINGS AND PUBLISHED AS
ABSTRACTS

1.
Ballin A, Kenet G, Tamari H., Rechavi G., Chividalli G., Burstein Y., Tmnber T., Nussinovitch M., Meytes D: Infantile idiopathic thrombocytopenic, Tiberias, Israel 1989 Ballin A., Kenet G: Antologous cord blood transfusion 11th meeting of the International Society of Hematology, European and African division, Basel, Switzerland, 1991 Also presented at the Israeli Society of Hematology, Tel Hashomer, Israel 1991. Ballin A., Kenet G: Cervical lymphadenopathy and atopy in childhood. The Israeli Association of Pediatrics, Tel-Aviv, Israel, 1992. Kenet G., Newmann Y., Winograd I., Efrati Y., Lotan G., Mandel M., Kende G., Toren A., Rechavi G: Malignant small cell desmoplastic tumor of childhood. The 9th Israel Medical week, Jerusalem 1993 Newmann Y., Toren A., Rechavi G., Mandel M., Kenet G., Golan-Shoam N., Ben-Bassat I., Sadeh M., Navon R: Vincristine treatment triggering the expression of a previously asymptomatic charcot Marie-Tooth disease. The Mandel M., Toren A., Newmann Y, Kenet G., Sharon N., Hardan I, Rechavi G: Peripheral stem-cell transplantation for pediatric patients with malignancies. The Tel-Aviv University Cancer Biology Research, Centeon Annual Meeting, Eilat Israel 1995 Kenet G., Lubetsky A., Shenkman B., Tamarin I., Dardik R., Savion N., Martinowitz U., Varon D: Primary hemostasis analyser (PHA) test for prediction of bleeding among thrombocytopenic patients. The 38th Meeting of the American Society of Hematology, Orlando, Florida, USA, 1996 Shenkman B., Linden N., Kenet G., Savion N., Tamarin I., Dardik R., German B., Varon D: Platelet function of neonates evaluation under shear-flow conditions. Israeli Society of Pediatric Hematology-Oncology. Mitzpe-Ramon, Israel, 1997. Inbal A., Kenet G., Freedman JE., Michelson AD., Brand N., Loscalzo J: Impaired NO-mediated inhibition of platelet aggregation and P-selection expression by plasma from patients with childhood stroke. Throm Haemost Suppl (Abs) 1997, The XVIth Congress of the International Society of Thrombosis and Haemostasis, Florence, Italy, 1997 Zivelin A., Rosenberg N., Dardik R., Amit Y., Kenet G., Kornbrot N., Fridman A., Seligshon U: A low frequency of two genetic risk factors for thrombosis in Yemenile-jews who manifest a decreased incidence of coronary artery disease. Throm Haemost Suppl (Abs) 1997, The XVIth Congress of the International Society of Thrombosis and Haemostasis, Florence, Italy, 1997 Kenet G., Lubetzky A., Tamarin I., Rechavi G., Barzilai A., Martinowitz U., Savion N., Varon D: Cone and Platelet Analyser: a new test for prediction of bleeding among thrombocytopenic patients. The Israeli Society of Pediatric Hematology-Oncology, Israel, 1998. Hayek S., Kenet G., Lubetzky A., Keret D., Weintroub S: Does thrombophilia play an ethiologycal role in Legg-Calve-Perthes Disease? The EPOS-IFPOS Meeting, Madrid, Spain 1998. Kenet G., Freedman J., Shenkman B., Eskaraev R., Brok-Simoni F., Holzman F., Vavva F., Brand N., Michelson A., Trolliet M., Loscalzo J., Inbal A: Plasma Gluthatione Peroxidose deficiency and platelet insensitivity to Nitric Oxide in children with familial stroke. The Israeli Society of Pediatric Hematology Oncology, 1999. G., Martinowitz U: Continuous infusion of recombinant VIIa. The 5th Novo Nordisk Symposium on the treatment of bleeding and thrombotic disorders, Copenhagen, Denmark, 1999. G., Martinowitz U., Lubetzky A., Gitel S., Varon D.: Continuous infusion of recombinant VIIa comparison of 2 protocols. XVII Congress of the International Society on Thrombosis and Haemostasis, Washington DC, USA 1999 G., Rosenberg N., Martinowitz U., Gitel S., Rechavi G., Seligshon U., Inbal A: Prevalence of thrombophilia risk factors among children with stroke. XVII Congress of the International Society on Thrombosis and Haemostasis, Washington DC, USA 1999 Zivelin A., Peretz H., Kornbrot N., Livnat T., Bulvik S., Kenet G., Seligshon U: Identification of 3 novel mutations in the factor XI gene in jewish patients. XVII Congress of the International Society on Thrombosis and Haemostasis, Washington DC, USA 1999 Martinowitz U., Kenet G., Luboshitz J., Lubetzky A., Varon D: Recombinant FVIIa (rFVIIa) for salvage of surgical patients suffering uncontrolled bleeding. Annual Meeting of the American Society of Hematology, New Orleans, 1999. Also presented by G. Kenet at the Israeli Society of Hematology, Dead Sea, Israel, 1999. Kenet G, Sadetzki S., Murad H., Martinowitz U., Rosenberg N., Gitel S., Rechavi G., Inbal A: Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. The Israeli Society of Pediatric Hematology Oncology, Dead Sea, Israel,2000 Luboshitz J, Lubetsky A, Kenet G, Shenkman B, Tamarin I, Martinowitz U and Varon D: Monitoring VWF replacement therapy:application of the CPA method compared to a standard method. World Federation of Hemophilia, Montreal 2000 Kenet G, Lubetsky A, Luboshitz J, Gitel S, Varon D and Martinowitz U: Treatment of inhibitor patients with rFVIIa: continuous infusion protocols as compared to a single, large dose. World Federation of Hemophilia, Montreal 2000 Kenet G, Luboshitz J, Lubetsky A, Varon D and Martinowitz U: Recombinant FVIIa (rFVIIa) in treatment of uncontrolled bleeding of haemophilia A patients without inhibitors. World Federation of Hemophilia, Montreal 2000 Kenet G, Lubetsky A, Luboshitz J, Varon D and Martinowitz U: A single megadose of rFVIIa for treatment of hemophilia patients with inhibitors. ASH, San-Francisco,2000 Kenet G. Use of rFVIIa in patients without preexisting coagulation disorders. GTH, Kenet G. Standard, high and mega bolus doses of novoseven-comparison of different treatment regimens-a single center experience. The Novonordisk symposium, Copenhagen 2001 Kenet G. The use of novoseven for profuse bleeding in surgical patients. The 26. Kenet G. Treatment of young hemophilia patients with inhibitors by recombinant activated factor VIIa. The annual Pediatric Hematology Congress, Ankara, 2001 27. Kenet G. Management of catastrophic bleeding episodes. ASH, Orlando, 2001 28. Kenet G, Martinowitz U : Circumcision in neonates with Hemophilia. WFH, Seville, 2002 Kenet G, Lubetsky A, Inbal A et al: Pediatric stroke in Israel. SSC of ISTH, Boston, 2002 Kenet G: Catastrophic trauma and massive hemorrhage in: Excessive bleeding in bone-marrow transplantation, ASBMT, Keystone, USA, 2003 Kenet G, Lubetsky A, Hayek S, Miller L, Rosenberg N, Mor M, Elstein D, Weitroub S, Zimran A. Gaucher mutations in Legg-Calve –Perthes disease: misdiagnosis or a new modifier gene? ISPHO, Cessaria, 2003 Kenet G: Pediatric thrombophilia-have we figured it all out? Israeli Society of Clinical Pediatrics, Tel-Aviv, 2003 Kenet G: Pediatric Cerebral sinus vein thrombosis and thrombophilia – a multi center case controlled study ISTH Birmingham 2003

Source: http://www.hemophilia.co.il/documents/kenetcv.pdf